E-mail

E-mail a Wiley Online Library Link

M. V. Kopp, E. Hamelmann, S. Zielen, W. Kamin, K.-C. Bergmann, C. Sieder, S. Stenglein, S. Seyfried, U. Wahn and for the DUAL study group Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma Clinical & Experimental Allergy 39

Version of Record online: 30 OCT 2008 | DOI: 10.1111/j.1365-2222.2008.03121.x

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH